Loading...
•
Dec 30, 2023
Masimo Q4 2023 Earnings Report
Masimo's Q4 2023 financial results were announced, featuring consolidated revenue of $548.9 million and non-GAAP EPS of $1.25.
Key Takeaways
Masimo reported consolidated revenue of $548.9 million for Q4 2023. GAAP net income per diluted share was $0.63, and non-GAAP net income per diluted share was $1.25. The company's healthcare sector revenue reached $339.9 million, while the non-healthcare sector contributed $209.0 million.
Consolidated revenue reached $548.9 million.
Healthcare revenue amounted to $339.9 million.
Non-healthcare revenue totaled $209.0 million.
Non-GAAP net income per diluted share was $1.25.
Masimo
Masimo
Forward Guidance
Masimo provided estimates for its first quarter and full-year 2024 guidance.
Positive Outlook
- Q1 2024 Consolidated revenue is expected to be between $476 million and $501 million.
- Q1 2024 Healthcare revenue is projected to range from $331 million to $341 million.
- Q1 2024 Non-healthcare revenue is anticipated to be in the range of $145 million to $160 million.
- Full-Year 2024 Consolidated revenue is projected to be between $2,045 million and $2,165 million.
- Full-Year 2024 Healthcare revenue is expected to range from $1,345 million to $1,385 million.
Challenges Ahead
- Q1 2024 Consolidated operating profit is expected to be between $35 million and $41 million.
- Q1 2024 Consolidated earnings per diluted share is projected to be between $0.32 and $0.40.
- Full-Year 2024 Consolidated operating profit is projected to be between $198 million and $214 million.
- Full-Year 2024 Consolidated earnings per diluted share is expected to be between $1.91 and $2.08.
- Q1 2024 Non-GAAP operating income (prior definition) is expected to be between $55 million and $61 million.